These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility. Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M. J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567 [Abstract] [Full Text] [Related]
27. Cefaclor AF: correlation of microbiology and clinical outcome. Thornsberry C. Postgrad Med J; 1992 Sep; 68 Suppl 3():S10-6. PubMed ID: 1287612 [Abstract] [Full Text] [Related]
29. Summary of laboratory studies on the antibacterial activity of cefaclor. Preston DA. Postgrad Med J; 1979 Sep; 55 Suppl 4():22-9. PubMed ID: 398479 [Abstract] [Full Text] [Related]
35. In vitro susceptibilities of common pediatric pathogens to LY163892. Shelton S, Nelson JD. Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989 [Abstract] [Full Text] [Related]
36. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin]. Etesse-Carsenti H, Caillon J, Mondain V, Durant J, Bernard E, Dellamonica P, Drugeon HB. Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716 [Abstract] [Full Text] [Related]
37. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens. Nord CE, Lindmark A, Persson I. Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384 [Abstract] [Full Text] [Related]
38. Bacterial isolates and cigarette smoking in patients with chronic bronchitis: results from an Italian multicenter survey. Cazzola M, Ariano R, Gioia V, Mancini V, Rimoldi R, Scala G, Scoccia S, Girbino G. Clin Ther; 1990 Feb; 12(2):105-17. PubMed ID: 2112984 [Abstract] [Full Text] [Related]
39. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. Cizman M, Pokorn M, Seme K, Orazem A, Paragi M. J Antimicrob Chemother; 2001 Apr; 47(4):475-7. PubMed ID: 11266425 [Abstract] [Full Text] [Related]
40. Comparative in vitro activity of A-56268 against respiratory tract pathogens. Jansson L, Kalin M. Eur J Clin Microbiol; 1987 Aug; 6(4):494-6. PubMed ID: 2959474 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]